Aura Biosciences (AURA) Equity Ratio (2020 - 2026)

Aura Biosciences has reported Equity Ratio for 7 years, with the latest figure at 0.78 in Q1 2026.

• For the quarter ending Q1 2026, Equity Ratio fell 5.4% year-over-year to 0.78; the trailing twelve-month figure through Mar 2026 stood at 0.78 (down 5.4% YoY), and the FY2025 full-year result was 0.81, down 2.96% from the prior year.
• Equity Ratio for Q1 2026 stood at 0.78, down from 0.81 in the prior quarter.
• The five-year high for Equity Ratio was 0.96 in Q1 2022, with the low at 0.78 in Q1 2026.
• Historically, Equity Ratio has averaged 0.86 across 5 years, with a median of 0.85 in 2025.
• Annual changes were most pronounced in 2022 — Equity Ratio soared 155.64% — and 2023, when it decreased 9.68%.
• Aura Biosciences' Equity Ratio stood at 0.87 in 2022, then gained by 1.38% to 0.89 in 2023, then slipped by 5.95% to 0.83 in 2024, then declined by 2.96% to 0.81 in 2025, then fell by 3.6% to 0.78 in 2026.
• The last three Equity Ratio figures came in at 0.78 (Q1 2026), 0.81 (Q4 2025), and 0.82 (Q3 2025), per Business Quant data.